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Healthcare workers (HCW) are potentially at increased 
risk of infection with coronavirus disease (COVID-19) 
and may transmit severe acute respiratory syndrome 
coronavirus 2 (SARS-CoV-2) to vulnerable patients. We 
present results from staff testing at Sheffield Teaching 
Hospitals NHS Foundation Trust, United Kingdom. 
Between 16 and 29 March 2020, 1,533 symptomatic 
HCW were tested, of whom 282 (18%) were positive for 
SARS-CoV-2. Testing HCW is a crucial strategy to opti-
mise staffing levels during this outbreak.
The coronavirus disease (COVID-19) pandemic has 
posed an unprecedented challenge for healthcare sys-
tems throughout the world. As at 6 April 2020, Public 
Health England (PHE) have reported 51,608 cases in the 
United Kingdom (UK) and 5,373 deaths [1]. We report 
the results from the first fortnight following the roll-
out of staff testing for COVID-19 at Sheffield Teaching 
Hospitals NHS Foundation Trust, UK.
Establishing a programme for staff testing 
at Sheffield Teaching Hospitals NHS 
Foundation Trust
Sheffield Teaching Hospitals NHS Foundation Trust 
(STH) is one of the UK’s largest foundation trusts, 
employing ca 17,000 individuals and providing a range 
of hospital and community services. On 17 March 
2020, STH commenced testing of symptomatic staff 
for severe acute respiratory syndrome coronavirus 2 
(SARS-CoV-2), coordinated by the Occupational Health 
department. Staff members presenting with an influ-
enza-like illness (defined as a reported fever AND one 
of: cough, sore throat, runny nose, myalgia, headache) 
or persistent cough, were directed to self-swab in the 
on-site assessment pods previously used for testing of 
ambulatory patients in the community. Written and pic-
torial instructions were provided to staff to self-swab 
the back of the oropharynx and then insert the same 
swab 4–6 cm to the back of the nasopharynx.
The Sigma-Virocult swabs (Medical Wire, Corsham, UK), 
containing viral transport medium, were transported to 
the hospital laboratory at least four times daily. Nucleic 
acid extraction was performed using MagNA Pure 
96 (Roche Life Sciences, Basel, Switzerland). Real-
time RT-PCR was performed using the ABI LightCycler 
(Applied Biosystems, Foster City, United States) with 
primers and probes specific for both RNA-dependent 
RNA polymerase (RdRP) and envelope (E) genes [2]. 
Samples with positive amplification curves for both 
RdRP and E, or samples with an E amplification curve 
alone and a cycle threshold less than 35, were consid-
ered positive. Samples with E amplification alone but a 
cycle threshold of 35 or greater were considered inde-
terminate and sent away for further testing. RNAaseP 
was used as an internal control to ensure good cellular 
content of the sample.
The majority of test results were communicated to 
staff on the same or the next day. Staff with a nega-
tive SARS-CoV-2 test were able to return to work if they 
felt well enough to do so. The policy was authorised by 
hospital management on 17 March.
We present the data from the first fortnight of staff 
testing. Test results were obtained from electronic lab-
oratory systems. Where available, details of staff roles 
and their work patterns since the onset of symptoms 
were obtained through their electronic clinical record. 
However, owing to the volume of work in the virology 
department, no electronic clinical records were cre-
ated for positive staff from 22 March 2020. This report 
is a description of the standard clinical care provided 
to staff at Sheffield Teaching Hospitals. Following 
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application of the NHS Health Research Authority 
algorithm (available at  http://www.hra-decisiontools.
org.uk/research/), it was decided that no formal ethi-
cal approval from the Institutional Review Board was 
required to produce this report.
Roll-out of staff testing at Sheffield 
Teaching Hospitals NHS Foundation Trust
In the week commencing 16 March, 451 staff mem-
bers were tested for SARS-CoV-2 with 58 (13%) posi-
tive. In the following week, 1,082 additional staff were 
tested, and 20 staff were retested because of worsen-
ing symptoms, with 224 (20%) positive. Of the 20 staff 
retested, three were positive and 17 remained negative 
for SARS-CoV-2. Overall 282 of 1,533 (18%) staff tested 
positive, 1,246 of 1,533 (81%) tested negative and five 
of 1,533 (< 1%) had an indeterminate result. All samples 
contained sufficient human cellular material.  Figure 
1  details the daily breakdown of SARS-CoV-2 staff 
testing.
Analysis of the first week of staff testing (16 
to 22 March 2020)
Among staff positive for SARS-CoV-2 for whom data 
were recorded (n = 52), 25 were nursing staff, eight 
were doctors, nine were other patient-facing clini-
cal staff, nine were laboratory or secretarial staff and 
one worked in cleaning services. Regarding symp-
toms, where data were recorded (n = 48), 23 had not 
worked with any symptoms, seven had been at work 
when symptoms developed and had left work on the 
same day, and 18 had worked at least one full shift 
with symptoms which were subsequently attributed to 
COVID-19 disease. None of the staff who tested posi-
tive for SARS-CoV-2 required hospital admission at the 
time of their positive result. In the week when staff 
testing was started, between 16 and 20 March 2020, 
the Occupational Health department received 4,337 
phone calls, compared with 998 calls between 9 and 
13 March 2020.
Contextualisation of staff testing at 
Sheffield Teaching Hospitals NHS 
foundation trust within UK policy and PHE 
guidance
From 12 March 2020, in the UK, community testing was 
discontinued and any person with a fever or a new per-
sistent cough was advised to self-isolate for 7 days, in 
order to enable UK laboratories to deliver priority test-
ing for increasing numbers of hospitalised patients [3]. 
From 16 March, asymptomatic household members of 
any person with a fever or new cough were advised to 
self-isolate for 14 days [4]. The combined impact has 
meant that healthcare workers (HCW) with symptoms 
or with a symptomatic household member have been 
unable to work, exacerbating pre-existing staff short-
ages in frontline services in the National Health Service 
(NHS). In a survey of 5,194 doctors across the UK con-
ducted over 24 h on 17 March, 12.8% were unable to 
work because they were symptomatic, and a further 
15.1% were unable to work because of a symptomatic 
household contact (Michael Marks, personal commu-
nication, 26 March 2020). At that time, PHE guidance 
stated that frontline staff who had been exposed to 
patients with confirmed SARS-CoV-2 infection without 
wearing personal protective equipment should con-
tinue to work so long as they remain asymptomatic 
[5]. This scenario has led to anxiety among exposed 
staff. Furthermore, in these conditions, staff members 
with only mild symptoms may feel pressured to con-
tinue working.  Figure 2  describes the timeline of key 
guidance impacting HCW in relation to the COVID-19 
outbreak in the UK.
Discussion
Our data demonstrate that the majority of staff who 
reported symptoms during the first fortnight of staff 
testing were negative for SARS-CoV-2. In a time where 
healthcare systems are particularly stretched, it is 
important to be able to maximise the available work-
force. Facilitating testing may substantially decrease 
absence in staff when SARS-CoV-2 can be excluded. 
The sensitivity, and therefore the false-negative rate, 
of the two-gene target RT-PCR assay has not been for-
mally described in the early stages of illness. However, 
SARS-2-CoV viral load in upper respiratory secretions 
is highest between 1 and 5 days from symptom onset, 
which is the optimal time to test symptomatic HCW 
[6]. If this test is negative, provided HCW are well and 
their symptoms have resolved (except for cough which 
is known to persist following any respiratory viral ill-
ness), it is reasonable that they return to work. Another 
major issue for healthcare staffing in the UK is that 
asymptomatic HCW must self-isolate for 14 days when 
they have a symptomatic family member. An additional 
boost to the workforce could be provided by access to 
testing for symptomatic household members of HCW.
The nature of work performed by healthcare profes-
sionals means that they may be at increased risk of 
COVID-19 infection and can also transmit infection to 
vulnerable patients [7]. More than a third of staff had 
Figure 1
Daily breakdown of SARS-CoV-2 tests performed on staff 
at Sheffield Teaching Hospitals Foundation Trust, 16–29 
March 2020 (n = 1,533)
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completed at least one shift while symptomatic. A limi-
tation of this report is that exact symptoms have not 
been recorded. Therefore, precise assessment of pro-
portion of staff meeting PHE criteria for self-isolation is 
not possible. However, during contact of staff members 
testing positive for SARS-CoV-2, we ascertained that 
most staff who had continued to work had only mild 
or non-specific symptoms at the time of clinical work. 
Early non-specific symptoms are challenging as HCWs 
may inadvertently expose other staff and patients 
before overt clinical symptoms manifest. Subclinical 
and asymptomatic infection has been reported, but its 
role in transmission is not clear [8-11]. Testing asympto-
matic staff would have significant practical limitations 
and is not feasible with testing capacity in the UK. 
However, testing staff with mild or non-specific symp-
toms should be considered for infection control pur-
poses, taking into account the practical implications of 
last-minute staff cover, optimal timing for swabbing to 
reduce false-negative results and laboratory capacity 
for testing [12]. Another limitation of this report is the 
lack of data on the roles of every staff member tested, 
in order to be able to provide a detailed breakdown of 
infection rate among different staff groups.
Testing of staff at our institution may also have pro-
vided a limited snapshot of SARS-CoV-2 prevalence in 
the community (i.e. those not requiring hospital admis-
sion) with mild influenza-like illness or persistent 
cough. While it is important that the provision of test-
ing is carefully balanced with consideration of labora-
tory capacity, increasing laboratory capacity to allow 
widespread testing of NHS staff could be a vital tool in 
achieving adequate staffing during the COVID-19 out-
break, and reducing the risk of transmission to vulner-
able patients.
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